Data from a prospective study of Galleri, a multicancer early detection blood assay, suggest that this approach is feasible and shows some potential. Of participants whose results were confirmed positive, the test had a high accuracy rate in predicting tumor origin; it also pinpointed cancers for which standard screening does not exist.

You do not currently have access to this content.